- Home
- ABP vs NCSM Comparison
ABP vs NCSM Comparison
Compare ABP & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABP
- NCSM
- Stock Information
- Founded
- ABP 2004
- NCSM 2006
- Country
- ABP United States
- NCSM United States
- Employees
- ABP N/A
- NCSM N/A
- Industry
- ABP Biotechnology: Pharmaceutical Preparations
- NCSM Oilfield Services/Equipment
- Sector
- ABP Health Care
- NCSM Energy
- Exchange
- ABP Nasdaq
- NCSM Nasdaq
- Market Cap
- ABP 76.2M
- NCSM 68.4M
- IPO Year
- ABP N/A
- NCSM 2017
- Fundamental
- Price
- ABP $1.30
- NCSM $29.45
- Analyst Decision
- ABP
- NCSM
- Analyst Count
- ABP 0
- NCSM 0
- Target Price
- ABP N/A
- NCSM N/A
- AVG Volume (30 Days)
- ABP 2.1M
- NCSM 10.4K
- Earning Date
- ABP 02-18-2025
- NCSM 03-06-2025
- Dividend Yield
- ABP N/A
- NCSM N/A
- EPS Growth
- ABP N/A
- NCSM N/A
- EPS
- ABP N/A
- NCSM 16.77
- Revenue
- ABP $122,000.00
- NCSM $152,801,000.00
- Revenue This Year
- ABP N/A
- NCSM $13.26
- Revenue Next Year
- ABP N/A
- NCSM $6.32
- P/E Ratio
- ABP N/A
- NCSM $1.76
- Revenue Growth
- ABP N/A
- NCSM 3.66
- 52 Week Low
- ABP $0.95
- NCSM $14.73
- 52 Week High
- ABP $13.00
- NCSM $30.44
- Technical
- Relative Strength Index (RSI)
- ABP N/A
- NCSM 63.99
- Support Level
- ABP N/A
- NCSM $27.10
- Resistance Level
- ABP N/A
- NCSM $29.67
- Average True Range (ATR)
- ABP 0.00
- NCSM 1.25
- MACD
- ABP 0.00
- NCSM 0.09
- Stochastic Oscillator
- ABP 0.00
- NCSM 84.01
About ABP Abpro Holdings Inc Common Stock
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms, The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with global pharmaceutical and research institutions.
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc provides products and support services that facilitate the optimization of oil and natural gas well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's primary offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. Geographically, majority of revenue is generated from United States.